Search

A Trial to Evaluate Safety and Efficacy of a Product Named VGN-R09b in Patients With Parkinson's Disease

Trial Phase 1 Active, not recruiting March 30, 2026

A Phase 2 Study to Assess the Effects of SUL-238 on High Energy Phosphates With ³¹P-MRS in Patients With Early, Untreated Parkinson's Disease

Trial Phase 2 Recruiting March 30, 2026

High Frequency Light, Sound, and Tactile Stimulation to Improve Motor and Cognitive Deficits in Parkinson's Disease

Trial N/A Recruiting March 30, 2026

Endurance Exercise & Virtual Reality for Optimizing Cortical Excitability and Neuroplasticity in PD

Trial N/A Recruiting March 30, 2026

Dual Frequency Stimulation in Parkinson's Disease

Trial N/A Recruiting March 30, 2026

Blood Flow Restriction for Optimizing Balance in Parkinson's Disease

Trial N/A Recruiting March 30, 2026

Upper Extremity Rehabilitation With Virtual Reality in Parkinson's Disease Patients

Trial N/A Completed March 30, 2026

The Importance of Raising Awareness

News Brian Grant Foundation March 30, 2026

Clinical Efficacy of a telerehabilItation Protocol, for the Improvement of Balance in Degenerative Neurological Diseases

Trial N/A Active, not recruiting March 29, 2026

Exploring the Olfactory Mucosa, Blood and Urine for the Identification of Early Biomarkers of Parkinson's Disease, Atypical Parkinsonisms and Neurocognitive Disorders Due to Lewy Body Disease

Trial N/A Recruiting March 29, 2026

Effects of an Independent Walking Program With Walking Poles in People With Parkinson Disease

Trial N/A Terminated March 29, 2026

Implementing a National Biobank of PD With WGS and Functional Assessment of Polygenic Inheritance by iPSC Technology

Trial N/A Recruiting March 29, 2026

Neurosurgical Outcome Network

Trial N/A Recruiting March 29, 2026

Electrophysiology-based DBS Programming for PD

Trial N/A Recruiting March 29, 2026

Orthostatic hypotension in Parkinson disease.

Research CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne March 29, 2026

Autoimmune diseases are associated with increased neurodegenerative and cerebrovascular risk, while systemic corticosteroid exposure shows limited neurodegenerative and modest vascular associations.

Research IBRO neuroscience reports March 28, 2026

Decode the Ubiquitinome in Parkinson's Disease: From Pathological Aggregates to Targeted DUB Therapeutics.

Research Neuroscience bulletin March 28, 2026

Collaborative multi-agent conversational artificial intelligence for clinical support in Parkinson disease.

Research Parkinsonism & related disorders March 28, 2026

User Experiences of Behavioral and Psychological Change Techniques in a Walking-Based Mobile Exergame: Cross-Sectional Qualitative Study.

Research JMIR serious games March 27, 2026

Accelerated TMS for Apathy in PD

Trial N/A Recruiting March 26, 2026